Login | English | Deutsch

 Research Information System University of Greifswald




Original article | published - printed | peer reviewed | Open Access

Randomized, placebo-controlled study on efficacy, safety and tolerability of drug-induced defibrinogenation for sudden sensorineural hearing loss: the lessons learned.


EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY 2023 / March ; 280(9): 4009 - 4018






Bibliometric indicators



Impact Factor = 1.9

Citations (WOS) = 3

DOI = 10.1007/s00405-023-07896-z

PubMed-ID = 36881166


Authors

Weiss B*, Spiegel J, Becker S, Strieth S, Olzowy B, Bertlich M, Fořt T, Mejzlik J, Lenarz T, Ihler F1, Canis M


Abstract

Disturbance of cochlear microcirculation is discussed as final common pathway of various inner ear diseases. Hyperfibrinogenemia causing increased plasma viscosity is a possible factor for a critical reduction of cochlear blood flow that might lead to sudden sensorineural hearing loss (SSHL). The aim was to determine the efficacy and safety of drug-induced defibrinogenation by ancrod for SSHL.

Published in

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY


Year 2023
Month/Hj March
Impact Factor (2023) 1.9
Volume 280
Issue 9
Pages 4009 - 4018
Open Access ja
Peer reviewed ja
Article type Original article
Article state published - printed
DOI 10.1007/s00405-023-07896-z
PubMed-ID 36881166

Common journal data

Short name: EUR ARCH OTO-RHINO-L
ISSN: 0937-4477
eISSN: 1434-4726
Country: GERMANY (FED REP GER)
Language: English
Categories:
  • OTORHINOLARYNGOLOGY


Impact factor trend

Year Impact Factor
2008 0.843
2009 1.167
2010 1.214
2011 1.287
2012 1.458
2013 1.608
2014 1.545
2015 1.627
2016 1.66
2017 1.546
2018 1.75
2019 1.809
2020 2.503
2021 3.236
2022 2.6
2023 1.9
2024 2.2

FAQs | Legal Notice | Privacy Statement